About: Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 October 1989

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в жовтні 1989 (uk) article scientifique publié en 1989 (fr) im Oktober 1989 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'ochobre de 1989 (ast) scientific article published on 01 October 1989 (en)
publication date	wds:Q69724889-C56F8225-6C95-47FD-9156-B8B6E28DE05F
publication date	1989-10-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q69724889-BE7C2C7D-4136-4346-A23B-6431BE2B3092
language of work or name	English
author name string	wds:Q69724889-35309471-76C1-40FB-A2C5-3F99C755B8F3 wds:Q69724889-5C2A2157-31B0-4D82-B809-60030862E2E8 wds:Q69724889-8EBCA43D-22E5-474A-8E72-6AF5BE928A6E wds:Q69724889-9337A289-FD4B-450E-A966-3542CC1284EF wds:Q69724889-C1CAAF00-3930-4A30-823A-D902B1E53181 wds:Q69724889-C3EA1BC7-C498-4B20-B441-61E251B24BB6 wds:Q69724889-D22C3187-8859-43A8-8D45-11F2216CE219 wds:Q69724889-D7F8CC25-E740-483F-8DCA-9FE8540EB69A wds:Q69724889-EF20396A-41D9-453F-9332-68C4AFA06AC1 wds:Q69724889-F08699BC-6BB0-4667-88AD-D733E83CC55D
author name string	M Graham D Mahoney J Casper B Camitta L Munoz J J Shuster C Civin S Adair B Leventhal S Lauer
rdfs:label	Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study (en) Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study (nl)
skos:prefLabel	Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study (en) Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study (nl)
name	Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study (en) Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study (nl)
title	wds:Q69724889-80EAF0E7-90CA-465E-A0DD-8BDC30623EBA
title	Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study (en)
page(s)	wds:Q69724889-0D4AE794-8AFD-4B2D-B5A5-9A4F43547638
page(s)	1539-1544
instance of	wds:Q69724889-ABB0AF2A-BCD2-4682-82D7-A1CE8CDFDF93
instance of	scholarly article
main subject	wds:Q69724889-2582044B-CA7E-4E79-A6DC-85EAAECB2318 wds:Q69724889-A7361AEA-76A6-406B-A71A-BFC3D04BA251 wds:Q69724889-C21B36B4-851B-4ABD-9035-A6CFB7E5AD28
main subject	acute lymphocytic leukemia wd:Q418529 wd:Q422232
PubMed ID	wds:Q69724889-EF61652C-947E-4618-814A-23C16EE1D164
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2778483
PubMed ID	2778483
published in	wds:Q69724889-07809698-6255-451B-BEE1-42F71986F8C7
published in	Journal of Clinical Oncology
issue	wds:Q69724889-B46B6D39-C205-4A0E-93C3-7EB28F9AA6A0
volume	wds:Q69724889-26B0EE8C-51EA-445D-A4ED-805897D16342
issue	10
volume	7
DOI	wds:Q69724889-688EA846-4AFC-4885-B267-9EE5F8C39C24
DOI	http://dx.doi.org/10.1200/JCO.1989.7.10.1539
DOI	10.1200/JCO.1989.7.10.1539
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q69724889
is cites work of	Variability in methotrexate serum and cerebrospinal fluid pharmacokinetics in children with acute lymphocytic leukemia: relation to assay methodology and physiological variables Progress in childhood cancer: 50 years of research collaboration, a report from the Children's Oncology Group Red blood cell methotrexate and folate levels in children with acute lymphoblastic leukemia undergoing therapy: a Pediatric Oncology Group pilot study Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia Pharmacologic strategies for the treatment of meningeal malignancy Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia Acute lymphoblastic leukaemia Promising approaches in acute leukemia Autologous bone marrow transplantation in acute lymphoblastic leukaemia Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects Basis for effective combination cancer chemotherapy with antimetabolites Biology and treatment of acute lymphoblastic leukemia Lessons from 20 years of curative therapy of childhood acute leukaemia Current Pharmacological Treatment Approaches to Central Nervous System Leukaemia On the prognostic value of systemic methotrexate clearance in childhood acute lymphocytic leukemia Aminophylline for methotrexate-induced neurotoxicity Assay of 6-mercaptopurine and its metabolites in patient plasma by high-performance liquid chromatography with diode-array detection Advances in therapy for childhood non-B-lymphoblastic leukaemia A phase II trial of continuous-infusion 6-mercaptopurine for childhood leukemia The ochsner experience with acute lymphoblastic leukemia in childhood Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts and treatment outcome in children with B-progenitor-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG. Maintenance treatment and shared care in lymphoblastic leukaemia Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study Use of irradiated lymphocytes from immune donors for treatment of disseminated varicella
is cites work of	wds:Q37474395-5737D3EE-5DC7-4801-99CC-FB425A324559 wds:Q41175791-6C2A60A3-31B8-4A4A-A80A-44BECD08121E wds:Q42279602-DD4517FD-D968-4BAC-9D63-E4B9BA494C3F wds:Q68146589-CC163A85-8D39-404D-9144-C8C7D94E2FEF wds:Q73158657-FCB0FBC2-4715-44B6-8840-E24371A67709 wds:Q72414737-AE6297C3-612C-479E-A07D-91F663B776DA wds:Q33919546-7588AEE1-6C52-4140-B530-711A68926FF8 wds:Q35052183-A1BC9DE9-116B-4A81-B5A1-55DD409C3591 wds:Q45270387-2F4C15C6-5F32-4611-BC24-2B06DE002E1E wds:Q73514183-C7843128-2EDD-401F-927B-DC1450B600E6 wds:Q39231255-34839046-BA5F-47E5-9227-2C3361000BCF wds:Q33929477-C52CC971-ABF8-4995-83D2-7BC8098BC968 wds:Q40558267-8EA247BD-8E2A-4DFC-B0CD-8210D53257D5

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software